Bandingkan Harga & Kinerja Kedoya Adyaraya Tbk. (RSGK) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kedoya Adyaraya Tbk. dan Organon Pharma Indonesia Tbk.: Kedoya Adyaraya Tbk. diperdagangkan di Rp1.030 (kapitalisasi pasar 948,27 M, volume 24 jam 34,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kedoya Adyaraya Tbk. jauh lebih besar — sekitar 9,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RSGK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 948,27 M | 104,4 M |
Volume | 34,1 rb | — |
Lot | 341 | — |
Perputaran | 34,02 jt | — |
Harga Rata-rata | 997,71 | — |
Nilai Transaksi | 34,02 jt | — |
Harga Ekuilibrium Indikatif | 1.030 | — |
Volume Ekuilibrium Indikatif | 2 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kedoya Adyaraya Tbk.
PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Selengkapnya di halaman RSGK →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
